Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Vanderbilt University describes ligands for 5-HT3 receptors

July 26, 1996

MBP peptide analogues described as multiple sclerosis treatment

July 26, 1996

Yeda claims protein as potential autoimmune disease treatment

July 26, 1996

Chinoin describes new selegiline formulation

July 26, 1996

Raloxifene indicated for excess NPY associated disorders

July 26, 1996

Pierre Fabre reports 5-HT1A agonists

July 26, 1996

Duloxetine claimed for new indication

July 26, 1996

Positive safety profile reported on histamine H3 antagonist research

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...